AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 161 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $276,000 | -16.4% | 6,000 | 0.0% | 0.02% | -15.4% |
| Q2 2021 | $330,000 | +6.8% | 6,000 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $309,000 | +34.9% | 6,000 | +76.5% | 0.03% | +4.0% |
| Q1 2019 | $229,000 | -12.6% | 3,400 | 0.0% | 0.02% | -13.8% |
| Q3 2018 | $262,000 | -8.4% | 3,400 | 0.0% | 0.03% | -14.7% |
| Q2 2018 | $286,000 | +2.9% | 3,400 | 0.0% | 0.03% | -2.9% |
| Q1 2018 | $278,000 | +22.5% | 3,400 | 0.0% | 0.04% | +20.7% |
| Q3 2017 | $227,000 | +2.7% | 3,400 | 0.0% | 0.03% | -21.6% |
| Q4 2015 | $221,000 | -7.9% | 3,400 | 0.0% | 0.04% | -9.8% |
| Q3 2015 | $240,000 | -36.5% | 3,400 | 0.0% | 0.04% | -25.5% |
| Q2 2015 | $378,000 | +17.8% | 3,400 | 0.0% | 0.06% | +19.6% |
| Q1 2015 | $321,000 | -22.7% | 3,400 | -8.1% | 0.05% | -23.3% |
| Q4 2014 | $415,000 | +35.2% | 3,700 | -26.0% | 0.06% | +27.7% |
| Q3 2014 | $307,000 | +34.1% | 5,000 | 0.0% | 0.05% | +46.9% |
| Q2 2014 | $229,000 | – | 5,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |